Citation sources

Updated weekly. Details via Crossref
Crossref Scopus Google Scholar
18 23 Search
2024
CMTM 6 promotes the development of thyroid cancer by inhibiting NIS activity through activating the MAPK signaling pathway
Functional & Integrative Genomics
2024
Current advancements in PD-L1 modulation by CMTM6 in malignant tumors
Oncologie
2023
High expression of CMTM6 is a risk factor for poor prognosis of gastrointestinal tumors: A meta-analysis
Asian Journal of Surgery
2023
Suppression of Tumor or Host Intrinsic CMTM6 Drives Antitumor Cytotoxicity in a PD-L1–Independent Manner
Cancer Immunology Research
2023
CMTM6 is highly expressed in lung adenocarcinoma and can be used as a biomarker of a poor diagnosis
PeerJ
2023
Construction of stable membranal CMTM6-PD-L1 full-length complex to evaluate the PD-1/PD-L1-CMTM6 interaction and develop anti-tumor anti-CMTM6 nanobody
Acta Pharmacologica Sinica
2022
Identification of prognostic biomarkers in the CMTM family genes of human ovarian cancer through bioinformatics analysis and experimental verification
Frontiers in Genetics
2022
CMTM6, a potential immunotherapy target
Journal of Cancer Research and Clinical Oncology
2022
CMTM6 as a master regulator of PD-L1
Cancer Immunology, Immunotherapy
2022
Prognostic significance and immune characteristics of CMTM4 in hepatocellular carcinoma
BMC Cancer
2022
Loss of CMTM6 promotes DNA damage-induced cellular senescence and antitumor immunity
OncoImmunology
2022
CMTM6 inhibits tumor growth and reverses chemoresistance by preventing ubiquitination of p21 in hepatocellular carcinoma
Cell Death & Disease
2022
CMTM Family and Gastrointestinal Tract Cancers: A Comprehensive Review
Cancer Management and Research
2022
The clinical and prognostic significance of CMTM6/PD-L1 in oncology
Clinical and Translational Oncology
2022
CMTM6 and CMTM4 as two novel regulators of PD-L1 modulate the tumor microenvironment
Frontiers in Immunology
2021
Co-Expression with Membrane CMTM6/4 on Tumor Epithelium Enhances the Prediction Value of PD-L1 on Anti-PD-1/L1 Therapeutic Efficacy in Gastric Adenocarcinoma
Cancers
2021
The association between the expression of PD-L1 and CMTM6 in undifferentiated pleomorphic sarcoma
Journal of Cancer Research and Clinical Oncology
2021
Identification of Key Circulating Exosomal microRNAs in Gastric Cancer
Frontiers in Oncology
Additional cited-by details will be shown when available from Crossref